Revenue and Profit - Revenue for the year ended December 31, 2025, increased by approximately HKD 605.6 million or 14.8% to approximately HKD 4,696.7 million compared to the fiscal year 2024[2] - Profit for the year ended December 31, 2025, decreased by approximately HKD 77.8 million or 47.8% to approximately HKD 84.8 million compared to the fiscal year 2024[2] - The company reported a pre-tax profit of HKD 107,864,000 for the year ended December 31, 2025, compared to HKD 199,495,000 in 2024, showing a decline of about 46%[18] - Basic and diluted earnings per share for 2025 were HKD 3.45, down from HKD 7.89 in 2024, indicating a decline in profitability[44] Dividends - The board proposed a final dividend of HKD 0.5 per share, down from HKD 1.3 per share for the fiscal year 2024[1] - The company declared an interim dividend of HKD 0.5 per share for 2025, totaling HKD 8,750,000, and proposed a final dividend of the same amount, pending shareholder approval[43] Assets and Liabilities - Total assets as of December 31, 2025, amounted to HKD 3,244.0 million, an increase from HKD 2,556.9 million in the fiscal year 2024[4] - Total liabilities as of December 31, 2025, increased to HKD 2,164.8 million from HKD 1,557.2 million in the fiscal year 2024[5] - Cash and cash equivalents as of December 31, 2025, were HKD 367.8 million, up from HKD 262.4 million in the fiscal year 2024[4] - Trade receivables increased to HKD 862,385,000 in 2025 from HKD 649,369,000 in 2024, showing a growth of approximately 32.8%[46] - The total amount of trade and other receivables reached HKD 1,040,553,000 in 2025, up from HKD 807,095,000 in 2024, marking an increase of 28.9%[46] Costs and Expenses - Operating profit for the year ended December 31, 2025, was HKD 167.2 million, a decrease from HKD 244.6 million in the fiscal year 2024[2] - The cost of goods sold recognized as an expense increased to HKD 2,831,833,000 in 2025 from HKD 2,372,585,000 in 2024, reflecting an increase of approximately 19.3%[37] - The group’s total expenses for sales, distribution, administrative, and R&D costs amounted to HKD 4,584,668,000 in 2025, up from HKD 3,893,806,000 in 2024, reflecting an increase of approximately 17.7%[37] - Selling and distribution costs rose by about 19.3% to HKD 589,700,000, aligned with revenue growth, driven by increased marketing and transportation costs[74] Market Performance - Revenue from health and home products sales reached HKD 3,326,738,000 in 2025, up from HKD 2,728,901,000 in 2024, indicating a growth of about 22%[19] - The North American market generated revenue of HKD 1,773,633,000 in 2025, compared to HKD 1,624,615,000 in 2024, reflecting an increase of approximately 9.2%[17] - Revenue from the China market increased by approximately 6.2% to HKD 1,857,677,000, driven by growth in retail sales[71] - Sales in Europe and other overseas markets surged by approximately 48.4% to HKD 1,065,375,000, primarily from increased sales to European customers[71] Financial Position - The group reported interest income from bank deposits of HKD 2,768,000 for 2025, down from HKD 5,209,000 in 2024, representing a decrease of approximately 47.2%[34] - Financial costs rose to HKD 59,087,000 in 2025 from HKD 50,085,000 in 2024, marking an increase of approximately 18%[36] - The group’s income tax expense decreased to HKD 23,018,000 in 2025 from HKD 36,846,000 in 2024, a reduction of approximately 37.5%[41] Acquisitions and Investments - The group completed a step acquisition of MDKH, increasing its ownership from 45% to 55% for a cash consideration of EUR 5,000,000 (approximately HKD 45,392,000)[60] - The acquired business contributed revenue of HKD 603,752,000 and a net loss of HKD 11,562,000 from August 5 to December 31, 2025[68] - The group recognized goodwill of HKD 168,844,000 from the step acquisition, attributed to expected synergies and market position in Europe and the US[65] Employee and Operational Metrics - The total number of employees increased to 3,867, with total employee costs rising to approximately HKD 753,900,000[87] - Capital expenditures for the period were approximately HKD 92,800,000, up from HKD 65,800,000 in the previous fiscal year[78] Future Outlook - The company plans to adopt new accounting standards and interpretations effective from 2025, which are not expected to have a significant impact on current or future reporting periods[14] - The group plans to continue expanding in overseas markets, particularly in Europe and the United States, with a focus on increasing market share and customer base[84]
盛诺集团(01418) - 2025 - 年度业绩